
SSAA09E3
CAS No. 52869-18-8
SSAA09E3( N-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide )
Catalog No. M28596 CAS No. 52869-18-8
SSAA09E3 is a novel inhibitor of SARS-CoV replication, acting by preventing fusion of the viral membrane with the host cellular membrane.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 58 | Get Quote |
![]() ![]() |
10MG | 87 | Get Quote |
![]() ![]() |
25MG | 177 | Get Quote |
![]() ![]() |
50MG | 295 | Get Quote |
![]() ![]() |
100MG | 480 | Get Quote |
![]() ![]() |
500MG | 1035 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSSAA09E3
-
NoteResearch use only, not for human use.
-
Brief DescriptionSSAA09E3 is a novel inhibitor of SARS-CoV replication, acting by preventing fusion of the viral membrane with the host cellular membrane.
-
DescriptionSSAA09E3 is a novel inhibitor of SARS-CoV replication, acting by preventing fusion of the viral membrane with the host cellular membrane.
-
In VitroSSAA09E3 blocks viral entry by inhibiting fusion of the viral membrane with the host cell membrane.SSAA09E3 inhibits later stages of viral entry.
-
In Vivo——
-
SynonymsN-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number52869-18-8
-
Formula Weight327.33
-
Molecular FormulaC21H13NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (101.82 mM)
-
SMILESO=C(c1ccccc1)Nc(cc1)cc(C(c2c3cccc2)=O)c1C3=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Murcia C, et al. Tanjungides A and B: new antitumoral bromoindole derived compounds from Diazona cf formosa. isolation and total synthesis. Mar Drugs. 2014 Feb 21;12(2):1116-30.
molnova catalog



related products
-
(-)-Benzotetramisole
(-)-Benzotetramisole makes an efficient and selective catalyst. (-)-Benzotetramisole is a benzannulated derivative of the anthelmintic compound tetraimidazole 3 and is itself an effective catalyst for conversion.
-
PG 01037 dihydrochlo...
Dopamine D3 receptor antagonist.
-
FPR Agonist 43
FPR Agonist 43 is a dual agonist of formyl peptide receptor 1 and formyl peptide receptor 2 (FPR2)/ALX.